Acknowledgement
Supported by : National Research Foundation of the Korea (NRF), KRIBB
References
- Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30 (2013). https://doi.org/10.3322/caac.21166
- Sakuramoto, S. et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N. Engl. J. Med. 357, 1810-1820 (2007). https://doi.org/10.1056/NEJMoa072252
- Sasako, M. et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N. Engl. J. Med. 359, 453-462 (2008). https://doi.org/10.1056/NEJMoa0707035
- Lauren, P. The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification. Acta Pathol. Microbiol. Scand. 64, 31-49 (1965). https://doi.org/10.1111/apm.1965.64.1.31
- Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52, 6735-6740 (1992).
- Niwa, T. et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 70, 1430-1440 (2010). https://doi.org/10.1158/0008-5472.CAN-09-2755
- Issa, J. P. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4, 988-993 (2004). https://doi.org/10.1038/nrc1507
- Laird, P. W. Cancer epigenetics. Hum. Mol. Genet. 14 Spec No1, R65-R76 (2005). https://doi.org/10.1093/hmg/ddi113
- Baylin, S. B. & Ohm, J. E. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107-116 (2006). https://doi.org/10.1038/nrc1799
- Espina, V., Heiby, M., Pierobon, M. & Liotta, L. A. Laser capture microdissection technology. Expert. Rev. Mol. Diagn. 7, 647-657 (2007). https://doi.org/10.1586/14737159.7.5.647
- Fend, F. & Raffeld, M. Laser capture microdissection in pathology. J. Clin. Pathol. 53, 666-672 (2000). https://doi.org/10.1136/jcp.53.9.666
- Burgemeister, R. New aspects of laser microdissection in research and routine. J. Histochem. Cytochem. 53, 409-412 (2005). https://doi.org/10.1369/jhc.4B6421.2005
- Agar, N. S., Halliday, G. M., Barnetson, R. S. & Jones, A. M. A novel technique for the examination of skin biopsies by laser capture microdissection. J. Cutan. Pathol. 30, 265-270 (2003). https://doi.org/10.1046/j.0303-6987.2003.052.x
- Yazdi, A. S., Puchta, U., Flaig, M. J. & Sander, C. A. Laser-capture microdissection: applications in routine molecular dermatopathology. J. Cutan. Pathol. 31, 465-470 (2004). https://doi.org/10.1111/j.0303-6987.2004.00221.x
- Gu, H. et al. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat. Methods 7, 133-136 (2010). https://doi.org/10.1038/nmeth.1414
- Harris, E. Y., Ponts, N., Levchuk, A., Roch, K. L. & Lonardi, S. BRAT: bisulfite-treated reads analysis tool. Bioinformatics 26, (572-573 (2010). https://doi.org/10.1093/bioinformatics/btp706
- Clark, S. J., Harrison, J. & Frommer, M. CpNpG methylation in mammalian cells. Nat. Genet. 10, 20-27 (1995). https://doi.org/10.1038/ng0595-20
- Lee, J. et al. Presence of 5-methylcytosine in CpNpG trinucleotides in the human genome. Genomics 96, 67-72 (2010). https://doi.org/10.1016/j.ygeno.2010.03.013
- Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009). https://doi.org/10.1038/nprot.2008.211
- Kim, M. et al. LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer. Cancer Res. 68, 7147-7155 (2008). https://doi.org/10.1158/0008-5472.CAN-08-0667
- Kim, S. K. et al. A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients. Mol. Oncol. 8, 1653-1666 (2014). https://doi.org/10.1016/j.molonc.2014.06.016
- Kim, S. M. et al. Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology 55, 1443-1452 (2012). https://doi.org/10.1002/hep.24813
- Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202-209 (2014). https://doi.org/10.1038/nature13480
- Irizarry, R. A. et al. The human colon cancer methylome shows similar hypoand hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186 (2009). https://doi.org/10.1038/ng.298
- Lee, E. et al. Landscape of somatic retrotransposition in human cancers. Science 337, 967-971 (2012). https://doi.org/10.1126/science.1222077
- Hattori, N. & Ushijima, T. Epigenetic impact of infection on carcinogenesis: mechanisms and applications. Genome Med. 8, 10 (2016). https://doi.org/10.1186/s13073-016-0267-2
- Watson, S. A., Grabowska, A. M., El-Zaatari, M. & Takhar, A. Gastrin - active participant or bystander in gastric carcinogenesis? Nat. Rev. Cancer 6, 936-946 (2006). https://doi.org/10.1038/nrc2014
- Obrink, K. J. Histamine and gastric acid secretion. A review. Scand. J. Gastroenterol. Suppl. 180, 4-8 (1991).
- Chuang, C. N., Tanner, M., Chen, M. C., Davidson, S. & Soll, A. H. Gastrin induction of histamine release from primary cultures of canine oxyntic mucosal cells. Am. J. Physiol. 263(4 Pt 1), G460-G465 (1992).
- Lindstrom, E., Chen, D., Norlen, P., Andersson, K. & Hakanson, R. Control of gastric acid secretion:the gastrin-ECL cell-parietal cell axis. Com. Biochem Physiol. A Mol. Integr. Physiol. 128, 505-514 (2001).
- Waldum, H. L. et al. The cellular localization of the cholecystokinin 2 (gastrin) receptor in the stomach. Pharmacol. Toxicol. 91, 359-362 (2002). https://doi.org/10.1034/j.1600-0773.2002.910613.x
- Patel, Y. C. Somatostatin and its receptor family. Front. Neuroendocrinol. 20, 157-198 (1999). https://doi.org/10.1006/frne.1999.0183
- Jackson, K. et al. Epigenetic silencing of somatostatin in gastric cancer. Dig. Dis. Sci. 56, 125-130 (2011). https://doi.org/10.1007/s10620-010-1422-z
- Shi, X., Li, X., Chen, L. & Wang, C. Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer. Oncol. Lett. 6, 1794-1798 (2013). https://doi.org/10.3892/ol.2013.1614
- Kato, S., Aihara, E., Yoshii, K. & Takeuchi, K. Dual action of prostaglandin E2 on gastric acid secretion through different EP-receptor subtypes in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G64-G69 (2005). https://doi.org/10.1152/ajpgi.00397.2004
- Sheikh, S. P. Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function. Am. J. Physiol. 261(5 Pt 1), G701-G715 (1991).
- Sugino, Y. et al. Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene 26, 7401-7413 (2007). https://doi.org/10.1038/sj.onc.1210550
- Tian, L. et al. Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation. Cancer 113, 1396-1403 (2008). https://doi.org/10.1002/cncr.23694
- Cebola, I. et al. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer. Clin. Epigenetics 7, 74 (2015). https://doi.org/10.1186/s13148-015-0110-4
- Negrini, M. et al. MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer. Eur. J. Cancer Prev. 21, 442-448 (2012).
- Kermani, M. & Eliassi, A. Gastric acid secretion induced by paraventricular nucleus microinjection of orexin A is mediated through activation of neuropeptide Yergic system. Neuroscience 226, 81-88 (2012). https://doi.org/10.1016/j.neuroscience.2012.08.052
- Lee, H. M. et al. Stimulatory actions of insulin-like growth factor-I and transforming growth factor-alpha on intestinal neurotensin and peptide YY. Endocrinology 140, 4065-4069 (1999). https://doi.org/10.1210/endo.140.9.6969
- Hokari, R. et al. Increased expression and cellular localization of lipocalintype prostaglandin D synthase in Helicobacter pylori-induced gastritis. J. Pathol. 219, 417-426 (2009). https://doi.org/10.1002/path.2615
- Kalmar, A. et al. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer. Bmc. Cancer 15, 736 (2015). https://doi.org/10.1186/s12885-015-1687-x
- Campbell, J. D. et al. The Case for a Pre-Cancer Genome Atlas (PCGA). Cancer Prev. Res (Phila.) 9, 119-124 (2016). https://doi.org/10.1158/1940-6207.CAPR-16-0024
- Takeshima, H., Wakabayashi, M., Hattori, N., Yamashita, S. & Ushijima, T. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy. Carcinogenesis 36, 192-201 (2015). https://doi.org/10.1093/carcin/bgu238
- Liu, X. S. et al. Editing DNA methylation in the mammalian genome. Cell 167, 233-247e17 (2016). https://doi.org/10.1016/j.cell.2016.08.056
Cited by
- Premalignant lesions and gastric cancer: Current understanding vol.11, pp.9, 2018, https://doi.org/10.4251/wjgo.v11.i9.665
- ONECUT2 upregulation is associated with CpG hypomethylation at promoter‐proximal DNA in gastric cancer and triggers ACSL5 vol.146, pp.12, 2018, https://doi.org/10.1002/ijc.32946
- Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes vol.11, pp.11, 2018, https://doi.org/10.1038/s41419-020-03213-2
- Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential vol.11, pp.None, 2018, https://doi.org/10.3389/fonc.2021.663771